Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized, Scientifically Based Technologies in the Diagnosis and Treatment of SARS-CoV-2 as a Possible Cervical Cancer Risk Factor

NCT07325682 is registered in ClinicalTrials.gov with Oncology Center,Ministry Of Heath,Uzbekistan as lead sponsor.

NCT NCT07325682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07325682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized, Scientifically Based Technologies in the Diagnosis and Treatment of SARS-CoV-2 as a Possible Cervical Cancer Risk Factor
Lead sponsor
Oncology Center,Ministry Of Heath,Uzbekistan
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 30, 2025
Completion date
December 30, 2030
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer